The Department of Health and Human Services is funding early-stage clinical trials of ibogaine to treat opioid addiction and post-traumatic stress disorder through ARPA-H and NIDA.

From the articlePharmalittle: We're reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and moreAlso in US advances first government-funded trials of psychedelic drug ibogaine | Reuters